文献速递临床试验与 GCP医学教育与科研方法

通过心理社会、物理治疗与营养支持性数字干预减少轻中度长新冠患者的病假、改善工作能力与生活质量(MiLoCoDaS):一项随机对照试验的研究方案

Reducing sick leave, improving work ability, and quality of life in patients with mild to moderate Long COVID through psychosocial, physiotherapeutic, and nutritive supportive digital intervention (MiLoCoDaS): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2023-12-08

MiLoCoDaS 是一项随机对照试验方案,纳入 18-67 岁符合长新冠诊断标准的患者,比较三种强度的数字化干预:仅提供患者信息(假干预对照)、信息加互动数字工作簿、数字工作簿加每周在线研讨与讨论组。主要终点为 6 个月观察期内病假天数,次要终点为患者报告症状、生活质量与工作能力;计划每组 N=152,计入脱落共 N=600。

要点

  • 三组分别为仅信息(假干预对照)、信息加数字工作簿、数字工作簿加每周在线研讨与讨论组。
  • 主要终点为 6 个月观察期内病假天数,次要终点为症状、生活质量与工作能力。
  • 设计以 80% 把握度、I 类错误<0.05 检出增强组与假干预组间 Cohen=0.3 的效应量。

核心结论

  • 研究旨在比较三种强度的可快速推广数字化干预之间效应量是否存在差异,以加速轻中度长新冠患者的康复。

研究设计与样本

  • 随机对照试验方案,通过初级保健医生招募 18-67 岁符合长新冠诊断标准的患者并随机分配。
  • 在线干预使用学习平台(LMS,TYPO3 框架),含 12 次医疗、心理、物理治疗与营养内容课程。
  • 样本量按增强组与假干预组间 Cohen=0.3 效应量、80% 把握度、I 类错误<0.05 计算,每组 N=152,计入脱落共 N=600。

主要发现

  • 原文为研究方案,未报告干预效果结果。
  • 若两种干预中任一优于仅提供信息,MiLoCoDaS 将为轻中度长新冠这一常见且目前服务不足人群提供可快速推广数字干预的起点。

关键数值与推荐

  • 三种模式:仅患者信息(假干预,对照)、信息加含实践练习的互动数字工作簿(数字干预)、数字工作簿加每周一次在线研讨与讨论组(人际与同伴接触)。
  • 主要终点为 6 个月观察期内病假天数;次要终点为患者报告症状、生活质量与工作能力。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文指出若干局限与长新冠表现及纳入前病程的异质性有关。
  • 原文指出干预的可能效应在不同亚组间可能存在差异,因此将进行预先定义的次要分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Following SARS-CoV-2 infection, a relevant proportion of patients suffer from persistent or recurring sequela, even after initially mild primary illness. Many patients experience exhaustion and fatigue, rendering them incapable of working. Long COVID exerts a substantial burden on society and the healthcare system: at least 65 million people are currently affected worldwide. The underlying pathobiology is a complex derangement in several organ systems. To date, causal pharmaceutical therapies remain elusive. Waiting lists for specialist care are long. Rapidly scalable digital interventions offering support for the frequent subgroup of patients with mild to moderate impairment from Long COVID are urgently needed. The MiLoCoDaS study compares three intensities of a potentially rapidly scalable digital intervention aiming to accelerate recovery. The overall objective is to figure out if there is a difference in the effect sizes between these modalities. METHODS: The online intervention uses a learning platform (LMS, TYPO3 framework) comprising 12 sessions of medical, psychological, physiotherapeutic, and nutritional content. The three modalities differ as follows: patient information only (sham intervention, control), information plus interactive digital workbook including practical exercises (digital intervention), and the digital workbook augmented by once-weekly online seminars and discussion groups (person and peer-contact). Eligible patients are 18-67 years old satisfying Long COVID diagnostic criteria. Patients are recruited through primary care physicians and randomly allocated. The primary endpoint is the number of sick leave days during the 6-month observation period; secondary endpoints are patient-reported symptoms, quality of life, and work ability. The study size provides a power of 80% at a type I error of < 0.05 to show an effect size of Cohen = 0.3 between the augmented and the sham intervention (N = 152 per arm, total accounting for attrition N = 600). DISCUSSION: If one of the two interventions is superior to providing information alone, MiLoCoDaS would provide the starting point for a rapidly scalable digital intervention for the frequent and currently underserved patient group with mild to moderate impairment from Long COVID. Several caveats pertain to the heterogeneity of Long COVID manifestation and duration prior to inclusion. It is conceivable that the possible effect of the intervention may differ across subgroups. Therefore, a priori defined secondary analysis will be conducted. TRIAL REGISTRATION: German Clinical Trials Register (DRKS) DRKS00028964. Registered on 24 August 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Krotz A, Sosnowsky-Waschek N, Bechtel S, et al. Reducing sick leave, improving work ability, and quality of life in patients with mild to moderate Long COVID through psychosocial, physiotherapeutic, and nutritive supportive digital intervention (MiLoCoDaS): study protocol for a randomized controlled trial. Trials. 2023. PMID: 38066618. doi:10.1186/s13063-023-07819-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。